000132693 001__ 132693
000132693 005__ 20240229105027.0
000132693 0247_ $$2doi$$a10.1055/s-0036-1597946
000132693 0247_ $$2pmid$$apmid:28061520
000132693 0247_ $$2ISSN$$a0044-2909
000132693 0247_ $$2ISSN$$a0930-7249
000132693 0247_ $$2ISSN$$a0939-6764
000132693 0247_ $$2ISSN$$a0939-7248
000132693 0247_ $$2ISSN$$a1439-359X
000132693 037__ $$aDKFZ-2018-00350
000132693 041__ $$aeng
000132693 082__ $$a610
000132693 1001_ $$aBogs, Thomas$$b0
000132693 245__ $$aEsophageal Atresia with or without Tracheoesophageal Fistula (EA/TEF): Association of Different EA/TEF Subtypes with Specific Co-occurring Congenital Anomalies and Implications for Diagnostic Workup.
000132693 260__ $$aStuttgart$$bThieme$$c2018
000132693 3367_ $$2DRIVER$$aarticle
000132693 3367_ $$2DataCite$$aOutput Types/Journal article
000132693 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1525335008_2151
000132693 3367_ $$2BibTeX$$aARTICLE
000132693 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000132693 3367_ $$00$$2EndNote$$aJournal Article
000132693 520__ $$aEsophageal atresia with or without tracheoesophageal fistula (EA/TEF) represents the most common developmental malformation of the upper digestive tract. It is classified into six subtypes according to the classification of Vogt, depending on anatomical variation of this malformation. Around 50% of the patients with EA/TEF present additional anomalies, which often influence, next to the EA/TEF subtype, the overall prognosis of EA/TEF newborns. Here, we investigated the association of the different EA/TEF subtypes with co-occurring congenital anomalies in EA/TEF patients and demonstrate their implications for postnatal diagnostic workup. We investigated 333 patients of a large German multicenter study born between 1980 and 2012. After evaluation of all available clinical records, 235 patients were included in our analysis. We compared our results with existing data. The highest risk for co-occurring anomalies was seen in patients with most common Vogt 3b (p = 0.024), especially for additional gastrointestinal anomalies (p = 0.04). Co-occurring anomalies of the skin were significantly more common in patients with subtype Vogt 2 (p = 0.024). A significant correlation was observed for an impaired neurodevelopmental outcome and EA/TEF Vogt 3a (p = 0.041). Patients with EA/TEF showed a higher risk to present with any additional congenital anomaly compared with the general population (p < 0.001). Our results warrant thorough clinical workup for gastrointestinal anomalies especially in patients with Vogt 3b. Moreover, it might be necessary to focus on a thorough aftercare for neurocognitive development in patients with Vogt 3a. The here presented observations need to be confirmed by future studies.
000132693 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000132693 588__ $$aDataset connected to CrossRef, PubMed,
000132693 7001_ $$0P:(DE-He78)24384a6f8ea177302339629c6b4577a7$$aZwink, Nadine$$b1$$udkfz
000132693 7001_ $$aChonitzki, Vera$$b2
000132693 7001_ $$aHölscher, Alice$$b3
000132693 7001_ $$aBoemers, Thomas M$$b4
000132693 7001_ $$aMünsterer, Oliver$$b5
000132693 7001_ $$aKurz, Ralf$$b6
000132693 7001_ $$aHeydweiller, Andreas$$b7
000132693 7001_ $$aPauly, Marcus$$b8
000132693 7001_ $$aLeutner, Andreas$$b9
000132693 7001_ $$aUre, Benno M$$b10
000132693 7001_ $$aLacher, Martin$$b11
000132693 7001_ $$aDeffaa, Oliver Johannes$$b12
000132693 7001_ $$aThiele, Holger$$b13
000132693 7001_ $$aBagci, Soyhan$$b14
000132693 7001_ $$0P:(DE-He78)949e730cbc09d0e60687edbab1755d60$$aJenetzky, Ekkehart$$b15$$udkfz
000132693 7001_ $$aSchumacher, Johannes$$b16
000132693 7001_ $$aReutter, Heiko$$b17
000132693 773__ $$0PERI:(DE-600)2059082-9$$a10.1055/s-0036-1597946$$gVol. 28, no. 2, p. 176 - 182$$n2$$p176 - 182$$tEuropean journal of pediatric surgery$$v28$$x1439-359X$$y2018
000132693 909CO $$ooai:inrepo02.dkfz.de:132693$$pVDB
000132693 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24384a6f8ea177302339629c6b4577a7$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000132693 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)949e730cbc09d0e60687edbab1755d60$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000132693 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000132693 9141_ $$y2018
000132693 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000132693 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000132693 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000132693 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000132693 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J PEDIATR SURG : 2015
000132693 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000132693 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000132693 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000132693 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000132693 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000132693 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000132693 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000132693 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000132693 980__ $$ajournal
000132693 980__ $$aVDB
000132693 980__ $$aI:(DE-He78)C070-20160331
000132693 980__ $$aUNRESTRICTED